Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Objective
Primary Aims To reduce therapy associated toxicity for patients with non-metastatic hepatoblastoma (HB) and hepatocellular carcinoma (HCC) without adversely affecting long term outcomes.
